Metadata
Title | Oncology: Medical and Radiation Pain Intensity QuantifiedFHIR
Version | 1.0.000
Short Name | CMS157FHIR
GUID (Version Independent) | urn:uuid:b7b487bf-bc27-48c9-994f-6d095ff84500
GUID (Version Specific) | urn:uuid:0f0317d4-38c3-4b87-b0a9-9b74aaa9a466
CMS Identifier | 157FHIR
CMS Consensus Based Entity Identifier | 0384e
Effective Period | 2026-01-01 through 2026-12-31
Steward (Publisher) | American Society of Clinical Oncology
Developer | American Society of Clinical Oncology
Description | Percentage of patient visits, regardless of patient age, with a diagnosis of cancer currently receiving chemotherapy or radiation therapy in which pain intensity is quantified
Copyright | Copyright 2025 American Society of Clinical Oncology. All Rights Reserved.
Disclaimer | The Measure is not a clinical guideline, does not establish a standard of medical care, and has not been tested for all potential applications. The Measure, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes, e.g., use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of the Measure for commercial gain, or incorporation of the Measure into a product or service that is sold, licensed or distributed for commercial gain. Commercial uses of the Measure require a license agreement between the user and American Society of Clinical Oncology (ASCO) and prior written approval of ASCO. Contact measurement@asco.org for licensing this measure. Neither ASCO nor its members shall be responsible for any use of the Measure. The PCPI’s and American Medical Association’s significant past efforts and contributions to the development and updating of the Measures are acknowledged. ASCO is solely responsible for the review and enhancement ("Maintenance") of the Measure as of June 2020. ASCO encourages the use of the Measure by other health care professionals, where appropriate. THE MEASURE AND SPECIFICATIONS ARE PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND. Limited proprietary coding may be contained in the Measure specifications for convenience. A license agreement must be entered prior to a third party’s use of Current Procedural Terminology (CPT[R]) or other proprietary code set contained in the Measures. Any other use of CPT or other coding by the third party is strictly prohibited. ASCO and its members disclaim all liability for use or accuracy of any CPT or other coding contained in the specifications. CPT(R) contained in the Measure specifications is copyright 2004-2024 American Medical Association. LOINC(R) is copyright 2004-2024 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms(R) (SNOMED CT[R]) copyright 2004-2024 International Health Terminology Standards Development Organisation. ICD-10 is copyright 2024 World Health Organization. All Rights Reserved. Due to technical limitations, registered trademarks are indicated by (R) or [R].
Rationale | Pain is a commonly occurring symptom for cancer patients as 30% to 50% (510,000 to 850,000 each year based on current statistics) will experience moderate to severe pain (Wiffen, Wee, Derry, Bell, & Moore, 2017). Initial and ongoing pain assessments are essential to determine the pathophysiology of pain and ensure proper pain management. According to the National Comprehensive Cancer Network (NCCN, 2024), undertreatment of pain remains a problem among a significant subset of cancer patients, survival is linked with symptom control and pain management, and pain management contributes to broad quality of life improvement. Furthermore, NCCN notes that formal pain reevaluation is required at each contact to ensure that pain management therapies are successfully meeting patient-specific goals for comfort, function, and safety. Cancer patients have reported that pain interferes with their mood, work, relationships with other people, sleep and overall enjoyment of life (Moryl et al., 2018). Pain management is an essential part of oncologic management and contributes to a patient’s overall function and quality of life (NCCN, 2024). A recent analysis of registry data for chronic pain cancer patients found average pain intensity reported as mild (24.6% of patients), moderate (41.5%), and severe (33.9%). The study also indicated that patient report of pain relief is inversely related to the average pain intensity reported (Moryl et al., 2018). These data suggest that assessing and managing a cancer patient’s pain is critical and there remains significant room for improvement in assessing and mitigating cancer-related pain. A prospective study of changes in pain severity of cancer patients found that, at initial assessment, 47% of patients reported pain. At follow-up, the patients with pain at initial assessment reported reduced pain (32.2%), stable pain (48.2%) and worse pain (19.6%). Of the 53% of patients reporting no pain at initial assessment, 82.6% reported stable pain and 17.4% reported worse pain at follow-up assessment (Zhao et al., 2014). This study highlights the importance of initial and ongoing assessments of pain to identify gaps and ensure proper pain management.
Clinical Recommendation Statement | Screen all patients for pain at each contact. Routinely quantify and document pain intensity and quality as characterized by the patient (whenever possible). Include patient reporting of breakthrough pain, treatments used and their impact on pain, satisfaction with pain relief, pain interference, provider assessment of impact on function, and any special issues for the patient relevant to pain treatment and access to care. If necessary, get additional information from caregiver regarding pain and impact on function. Perform comprehensive pain assessment if new or worsening pain is present and regularly for persisting pain. Various methods and tools exist to assess pain severity. Intensity of pain should be quantified using a numerical rating scale (i.e., 0-10), visual analog scale, categorical scale, or pictorial scale (e.g., The Faces Pain Rating Scale) (Category 2A) (National Comprehensive Cancer Network, 2024).
Citation | Moryl, N., Dave, V., Glare, P., Bokhari, A., Malhotra, V. T., Gulati, A., … Inturrisi, C. E. (2018). Patient-Reported Outcomes and Opioid Use by Outpatient Cancer Patients. The Journal of Pain: official journal of the American Pain Society, 19(3), 278–290. doi:10.1016/j.jpain.2017.11.001
Citation | National Comprehensive Cancer Network (NCCN). (2024). NCCN Clinical Practice Guidelines in Oncology. Adult Cancer Pain Version 2.2024. Retrieved from http://www.nccn.org
Citation | Wiffen, P. J., Wee, B., Derry, S., Bell, R. F., & Moore, R. A. (2017). Opioids for cancer pain - an overview of Cochrane reviews. The Cochrane database of systematic reviews, 7(7), CD012592. doi:10.1002/14651858.CD012592.pub2
Citation | Zhao, F., Chang, V. T., Cleeland, C., Cleary, J. F., Mitchell, E. P., Wagner, L. I., & Fisch, M. J. (2014). Determinants of pain severity changes in ambulatory patients with cancer: an analysis from Eastern Cooperative Oncology Group trial E2Z02. Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 32(4), 312–319. doi:10.1200/JCO.2013.50.6071
Guidance (Usage) | This eCQM is an episode-based measure. An episode is defined as each eligible encounter for patients with a diagnosis of cancer who are also currently receiving chemotherapy or radiation therapy during the measurement period. For patients receiving radiation therapy, pain intensity should be quantified at each radiation treatment management encounter where the patient and physician have a face-to-face interaction. Due to the nature of some applicable coding related to radiation therapy (e.g., delivered in multiple fractions), the billing date for certain codes may or may not be the same as the face-to-face encounter date. In this instance, for the reporting purposes of this measure, the billing date should be used to pull the appropriate patients into the initial population. It is expected, though, that the numerator criteria would be performed at the time of the actual face-to-face encounter during the series of treatments. A lookback (retrospective) period of 7 days, including the billing date, may be used to identify the actual face-to-face encounter, which is required to assess the numerator. Therefore, pain intensity should be quantified during the face-to-face encounter occurring on the actual billing date or within the 6 days prior to the billing date. For patients receiving chemotherapy, pain intensity should be quantified at each face-to-face or telehealth encounter with the physician while the patient is currently receiving chemotherapy. For purposes of identifying eligible encounters, patients "currently receiving chemotherapy" refers to patients administered chemotherapy on the same day as the encounter or during the 30 days before the date of the encounter AND during the 30 days after the date of the encounter. Pain intensity should be quantified using a standard instrument, such as a 0-10 numerical rating scale, visual analog scale, a categorical scale, or pictorial scale. Examples include the Faces Pain Rating Scale and the Brief Pain Inventory (BPI). This FHIR-based measure has been derived from the QDM-based measure: CMS157v14. Please refer to the HL7 QI-Core Implementation Guide (https://hl7.org/fhir/us/qicore/STU6/) for more information on QI-Core and mapping recommendations from QDM to QI-Core STU6 (https://hl7.org/fhir/us/qicore/STU6/qdm-to-qicore.html).
Measure Group (Rate) (ID: Group_1)
Summary | Percentage of patient visits, regardless of patient age, with a diagnosis of cancer currently receiving chemotherapy in which pain intensity is quantified
Basis | Encounter
Scoring | [http://terminology.hl7.org/CodeSystem/measure-scoring#proportion: 'Proportion']
Type | [http://terminology.hl7.org/CodeSystem/measure-type#process: 'Process']
Rate Aggregation | This measure is intended to have one reporting rate, which aggregates the following populations into a single performance rate for reporting purposes: Population 1: Visits for patients with a diagnosis of cancer who are currently receiving chemotherapy Population 2: Visits for patients with a diagnosis of cancer who are currently receiving radiation therapy For the purposes of this measure, a single performance rate can be calculated as follows: Performance Rate = (Numerator 1 + Numerator 2)/ (Denominator 1 + Denominator 2)
Improvement Notation | [http://terminology.hl7.org/CodeSystem/measure-improvement-notation#increase: 'Increased score indicates improvement']
Initial Population | ID: InitialPopulation_1 Description: All patient visits, regardless of patient age, with a diagnosis of cancer currently receiving chemotherapy Logic Definition: Initial Population 1
Denominator | ID: Denominator_1 Description: Equals Initial Population Logic Definition: Denominator 1
Numerator | ID: Numerator_1 Description: Patient visits in which pain intensity is quantified Logic Definition: Numerator 1
Measure Group (Rate) (ID: Group_2)
Summary | Percentage of patient visits, regardless of patient age, with a diagnosis of cancer currently receiving radiation therapy in which pain intensity is quantified
Basis | Encounter
Scoring | [http://terminology.hl7.org/CodeSystem/measure-scoring#proportion: 'Proportion']
Type | [http://terminology.hl7.org/CodeSystem/measure-type#process: 'Process']
Rate Aggregation | This measure is intended to have one reporting rate, which aggregates the following populations into a single performance rate for reporting purposes: Population 1: Visits for patients with a diagnosis of cancer who are currently receiving chemotherapy Population 2: Visits for patients with a diagnosis of cancer who are currently receiving radiation therapy For the purposes of this measure, a single performance rate can be calculated as follows: Performance Rate = (Numerator 1 + Numerator 2)/ (Denominator 1 + Denominator 2)
Improvement Notation | [http://terminology.hl7.org/CodeSystem/measure-improvement-notation#increase: 'Increased score indicates improvement']
Initial Population | ID: InitialPopulation_2 Description: All patient visits, regardless of patient age, with a diagnosis of cancer currently receiving radiation therapy Logic Definition: Initial Population 2
Denominator | ID: Denominator_2 Description: Equals Initial Population Logic Definition: Denominator 2
Numerator | ID: Numerator_2 Description: Patient visits in which pain intensity is quantified Logic Definition: Numerator 2
Supplemental Data Guidance | For every patient evaluated by this measure also identify payer, race, ethnicity and sex
Supplemental Data Elements
Supplemental Data Element | ID: sde-ethnicity Usage Code: [http://terminology.hl7.org/CodeSystem/measure-data-usage#supplemental-data] Description: SDE Ethnicity Logic Definition: SDE Ethnicity
Supplemental Data Element | ID: sde-payer Usage Code: [http://terminology.hl7.org/CodeSystem/measure-data-usage#supplemental-data] Description: SDE Payer Logic Definition: SDE Payer
Supplemental Data Element | ID: sde-race Usage Code: [http://terminology.hl7.org/CodeSystem/measure-data-usage#supplemental-data] Description: SDE Race Logic Definition: SDE Race
Supplemental Data Element | ID: sde-sex Usage Code: [http://terminology.hl7.org/CodeSystem/measure-data-usage#supplemental-data] Description: SDE Sex Logic Definition: SDE Sex
Measure Logic
Primary Library | https://madie.cms.gov/Library/CMS157FHIRPainIntensityQuantified
Contents | Population Criteria Logic Definitions Terminology Dependencies Data Requirements
Population Criteria
Measure Group (Rate) (ID: Group_1)
Initial Population
    define "Initial Population 1":
      "Face to Face or Telehealth Encounter with Ongoing Chemotherapy"
Denominator
    define "Denominator 1":
      "Initial Population 1"
Numerator
    define "Numerator 1":
      "Face to Face or Telehealth Encounter with Ongoing Chemotherapy" FaceToFaceOrTelehealthEncounterWithChemo
        with "Standard Pain Assessment with Result" PainAssessed
          such that PainAssessed.effective.toInterval ( ) during day of FaceToFaceOrTelehealthEncounterWithChemo.period
Measure Group (Rate) (ID: Group_2)
Initial Population
    define "Initial Population 2":
      "Radiation Treatment Management During Measurement Period with Cancer Diagnosis"
Denominator
    define "Denominator 2":
      "Initial Population 2"
Numerator
    define "Numerator 2":
      "Radiation Treatment Management During Measurement Period with Cancer Diagnosis" RadiationManagementEncounter
        with "Standard Pain Assessment with Result" PainAssessed
          such that case
            when exists ( ( RadiationManagementEncounter.type ) RadiationManagement
                where RadiationManagement ~ "Radiation treatment management, 5 treatments"
            ) then PainAssessed.effective.toInterval ( ) 6 days or less on or before day of start of RadiationManagementEncounter.period
            else PainAssessed.effective.toInterval ( ) during day of RadiationManagementEncounter.period end
Logic Definitions
Logic Definition | Library Name: SupplementalDataElements
    define "SDE Sex":
      case
        when Patient.sex = '248153007' then "Male (finding)"
        when Patient.sex = '248152002' then "Female (finding)"
        else null
      end
Logic Definition | Library Name: SupplementalDataElements
    define "SDE Payer":
      [Coverage: type in "Payer Type"] Payer
        return {
          code: Payer.type,
          period: Payer.period
        }
Logic Definition | Library Name: SupplementalDataElements
    define "SDE Ethnicity":
      Patient.ethnicity E
        return Tuple {
          codes: { E.ombCategory } union E.detailed,
          display: E.text
        }
Logic Definition | Library Name: SupplementalDataElements
    define "SDE Race":
      Patient.race R
        return Tuple {
          codes: R.ombCategory union R.detailed,
          display: R.text
        }
Logic Definition | Library Name: CMS157FHIRPainIntensityQuantified
    define "SDE Sex":
      SDE."SDE Sex"
Logic Definition | Library Name: CMS157FHIRPainIntensityQuantified
    define "Radiation Treatment Management During Measurement Period with Cancer Diagnosis":
      ( [Encounter: "Radiation Treatment Management"] ) RadiationTreatmentManagement
        with ( [ConditionProblemsHealthConcerns: "Cancer"]
          union [ConditionEncounterDiagnosis: "Cancer"] ) CancerDx
          such that CancerDx.prevalenceInterval ( ) overlaps day of RadiationTreatmentManagement.period
        where RadiationTreatmentManagement.period during day of "Measurement Period"
          and RadiationTreatmentManagement.status = 'finished'
Logic Definition | Library Name: CMS157FHIRPainIntensityQuantified
    define "Initial Population 2":
      "Radiation Treatment Management During Measurement Period with Cancer Diagnosis"
Logic Definition | Library Name: CMS157FHIRPainIntensityQuantified
    define "Denominator 2":
      "Initial Population 2"
Logic Definition | Library Name: CMS157FHIRPainIntensityQuantified
    define "Chemotherapy Within 31 Days Prior and During Measurement Period":
      [Procedure: "Chemotherapy Administration"] ChemoAdministration
        where ChemoAdministration.performed.toInterval ( ) during Interval[start of "Measurement Period" - 31 days, end of "Measurement Period"]
          and ChemoAdministration.status in { 'completed', 'in-progress' }
Logic Definition | Library Name: CMS157FHIRPainIntensityQuantified
    define "Face to Face or Telehealth Encounter with Ongoing Chemotherapy":
      from
        ( [Encounter: "Office Visit"]
          union [Encounter: "Audio Visual Telehealth Encounter"] ) FaceToFaceOrTelehealthEncounter,
        "Chemotherapy Within 31 Days Prior and During Measurement Period" ChemoBeforeEncounter,
        "Chemotherapy Within 31 Days Prior and During Measurement Period" ChemoAfterEncounter,
        ( [ConditionProblemsHealthConcerns: "Cancer"]
          union [ConditionEncounterDiagnosis: "Cancer"] ) CancerDx
        where CancerDx.prevalenceInterval ( ) overlaps day of FaceToFaceOrTelehealthEncounter.period
          and ChemoBeforeEncounter.performed.toInterval ( ) starts 30 days or less on or before day of end of FaceToFaceOrTelehealthEncounter.period
          and ChemoAfterEncounter.performed.toInterval ( ) starts 30 days or less on or after day of end of FaceToFaceOrTelehealthEncounter.period
          and not ( ChemoAfterEncounter.performed.toInterval ( ) same day as ChemoBeforeEncounter.performed.toInterval ( ) )
          and FaceToFaceOrTelehealthEncounter.period during day of "Measurement Period"
          and FaceToFaceOrTelehealthEncounter.status = 'finished'
        return FaceToFaceOrTelehealthEncounter
Logic Definition | Library Name: CMS157FHIRPainIntensityQuantified
    define "Standard Pain Assessment with Result":
      [ObservationScreeningAssessment: "Standardized Pain Assessment Tool"] AssessedPain
        where AssessedPain.value is not null
Logic Definition | Library Name: CMS157FHIRPainIntensityQuantified
    define "Numerator 1":
      "Face to Face or Telehealth Encounter with Ongoing Chemotherapy" FaceToFaceOrTelehealthEncounterWithChemo
        with "Standard Pain Assessment with Result" PainAssessed
          such that PainAssessed.effective.toInterval ( ) during day of FaceToFaceOrTelehealthEncounterWithChemo.period
Logic Definition | Library Name: CMS157FHIRPainIntensityQuantified
    define "SDE Payer":
      SDE."SDE Payer"
Logic Definition | Library Name: CMS157FHIRPainIntensityQuantified
    define "Numerator 2":
      "Radiation Treatment Management During Measurement Period with Cancer Diagnosis" RadiationManagementEncounter
        with "Standard Pain Assessment with Result" PainAssessed
          such that case
            when exists ( ( RadiationManagementEncounter.type ) RadiationManagement
                where RadiationManagement ~ "Radiation treatment management, 5 treatments"
            ) then PainAssessed.effective.toInterval ( ) 6 days or less on or before day of start of RadiationManagementEncounter.period
            else PainAssessed.effective.toInterval ( ) during day of RadiationManagementEncounter.period end
Logic Definition | Library Name: CMS157FHIRPainIntensityQuantified
    define "Initial Population 1":
      "Face to Face or Telehealth Encounter with Ongoing Chemotherapy"
Logic Definition | Library Name: CMS157FHIRPainIntensityQuantified
    define "SDE Ethnicity":
      SDE."SDE Ethnicity"
Logic Definition | Library Name: CMS157FHIRPainIntensityQuantified
    define "SDE Race":
      SDE."SDE Race"
Logic Definition | Library Name: CMS157FHIRPainIntensityQuantified
    define "Denominator 1":
      "Initial Population 1"
Logic Definition | Library Name: QICoreCommon
    /*
    @description: Normalizes a value that is a choice of timing-valued types to an equivalent interval
    @comment: Normalizes a choice type of DateTime, Quanitty, Interval<DateTime>, or Interval<Quantity> types
    to an equivalent interval. This selection of choice types is a superset of the majority of choice types that are used as possible
    representations for timing-valued elements in QICore, allowing this function to be used across any resource.
    The input can be provided as a DateTime, Quantity, Interval<DateTime> or Interval<Quantity>.
    The intent of this function is to provide a clear and concise mechanism to treat single
    elements that have multiple possible representations as intervals so that logic doesn't have to account
    for the variability. More complex calculations (such as medication request period or dispense period
    calculation) need specific guidance and consideration. That guidance may make use of this function, but
    the focus of this function is on single element calculations where the semantics are unambiguous.
    If the input is a DateTime, the result a DateTime Interval beginning and ending on that DateTime.
    If the input is a Quantity, the quantity is expected to be a calendar-duration interpreted as an Age,
    and the result is a DateTime Interval beginning on the Date the patient turned that age and ending immediately before one year later.
    If the input is a DateTime Interval, the result is the input.
    If the input is a Quantity Interval, the quantities are expected to be calendar-durations interpreted as an Age, and the result
    is a DateTime Interval beginning on the date the patient turned the age given as the start of the quantity interval, and ending
    immediately before one year later than the date the patient turned the age given as the end of the quantity interval.
    If the input is a Timing, an error will be thrown indicating that Timing calculations are not implemented. Any other input will reslt in a null DateTime Interval
    */
    define fluent function toInterval(choice Choice<DateTime, Quantity, Interval<DateTime>, Interval<Quantity>, Timing>):
      case
    	  when choice is DateTime then
        	Interval[choice as DateTime, choice as DateTime]
    		when choice is Interval<DateTime> then
      		choice as Interval<DateTime>
    		when choice is Quantity then
    		  Interval[Patient.birthDate + (choice as Quantity),
    			  Patient.birthDate + (choice as Quantity) + 1 year)
    		when choice is Interval<Quantity> then
    		  Interval[Patient.birthDate + (choice.low as Quantity),
    			  Patient.birthDate + (choice.high as Quantity) + 1 year)
    		when choice is Timing then
          Message(null, true, 'NOT_IMPLEMENTED', 'Error', 'Calculation of an interval from a Timing value is not supported') as Interval<DateTime>
    		else
    			null as Interval<DateTime>
    	end
Logic Definition | Library Name: FHIRHelpers
    define function ToString(value uri): value.value
Logic Definition | Library Name: FHIRHelpers
    /*
    @description: Converts the given [Period](https://hl7.org/fhir/datatypes.html#Period)
    value to a CQL DateTime Interval
    @comment: If the start value of the given period is unspecified, the starting
    boundary of the resulting interval will be open (meaning the start of the interval
    is unknown, as opposed to interpreted as the beginning of time).
    */
    define function ToInterval(period FHIR.Period):
        if period is null then
            null
        else
            if period."start" is null then
                Interval(period."start".value, period."end".value]
            else
                Interval[period."start".value, period."end".value]
Logic Definition | Library Name: FHIRHelpers
    /*
    @description: Converts the given FHIR [CodeableConcept](https://hl7.org/fhir/datatypes.html#CodeableConcept) value to a CQL Concept.
    */
    define function ToConcept(concept FHIR.CodeableConcept):
        if concept is null then
            null
        else
            System.Concept {
                codes: concept.coding C return ToCode(C),
                display: concept.text.value
            }
Logic Definition | Library Name: FHIRHelpers
    /*
    @description: Converts the given FHIR [Coding](https://hl7.org/fhir/datatypes.html#Coding) value to a CQL Code.
    */
    define function ToCode(coding FHIR.Coding):
        if coding is null then
            null
        else
            System.Code {
              code: coding.code.value,
              system: coding.system.value,
              version: coding.version.value,
              display: coding.display.value
            }
Terminology
Code System | Description: Code system SNOMEDCT Resource: http://snomed.info/sct Canonical URL: `http://snomed.info/sct`
Code System | Description: Code system CPT Resource: http://www.ama-assn.org/go/cpt Canonical URL: `http://www.ama-assn.org/go/cpt`
Value Set | Description: Value set Radiation Treatment Management Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1026 Canonical URL: `http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1026`
Value Set | Description: Value set Cancer Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1010 Canonical URL: `http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1010`
Value Set | Description: Value set Office Visit Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1001 Canonical URL: `http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1001`
Value Set | Description: Value set Audio Visual Telehealth Encounter Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.215 Canonical URL: `http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.215`
Value Set | Description: Value set Chemotherapy Administration Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1027 Canonical URL: `http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1027`
Value Set | Description: Value set Standardized Pain Assessment Tool Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1028 Canonical URL: `http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1028`
Value Set | Description: Value set Payer Type Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3591 Canonical URL: `http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3591`
Direct Reference Code | Display: Male (finding) Code: 248153007 System: `http://snomed.info/sct`
Direct Reference Code | Display: Female (finding) Code: 248152002 System: `http://snomed.info/sct`
Direct Reference Code | Display: Radiation treatment management, 5 treatments Code: 77427 System: `http://www.ama-assn.org/go/cpt`
Dependencies
Dependency | Description: QICore model information Resource: http://hl7.org/fhir/Library/QICore-ModelInfo Canonical URL: `http://hl7.org/fhir/Library/QICore-ModelInfo`
Dependency | Description: Library SDE Resource: https://madie.cms.gov/Library/SupplementalDataElements|5.1.000 Canonical URL: `https://madie.cms.gov/Library/SupplementalDataElements|5.1.000`
Dependency | Description: Library FHIRHelpers Resource: https://madie.cms.gov/Library/FHIRHelpers|4.4.000 Canonical URL: `https://madie.cms.gov/Library/FHIRHelpers|4.4.000`
Dependency | Description: Library QICoreCommon Resource: https://madie.cms.gov/Library/QICoreCommon|4.0.000 Canonical URL: `https://madie.cms.gov/Library/QICoreCommon|4.0.000`
Data Requirements
Data Requirement | Type: Patient Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient Must Support Elements: extension, birthDate, birthDate.value, url
Data Requirement | Type: Encounter Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-encounter Must Support Elements: type, period, status, status.value Code Filter(s): Path: type ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1026
Data Requirement | Type: Encounter Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-encounter Must Support Elements: type, period, status, status.value Code Filter(s): Path: type ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1001
Data Requirement | Type: Encounter Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-encounter Must Support Elements: type, period, status, status.value Code Filter(s): Path: type ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.215
Data Requirement | Type: Condition Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-problems-health-concerns Must Support Elements: code Code Filter(s): Path: code ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1010
Data Requirement | Type: Condition Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-encounter-diagnosis Must Support Elements: code Code Filter(s): Path: code ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1010
Data Requirement | Type: Procedure Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-procedure Must Support Elements: code, performed, status, status.value Code Filter(s): Path: code ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1027
Data Requirement | Type: Observation Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation-screening-assessment Must Support Elements: code, value, effective Code Filter(s): Path: code ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.1028
Data Requirement | Type: Coverage Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-coverage Must Support Elements: type, period Code Filter(s): Path: type ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3591
Generated using version 0.4.8 of the sample-content-ig Liquid templates